Skip to content
Congress·In Committee·3 months ago

Senate Bill Would Ban PBM "Spread Pricing" in Medicaid, Open Medicare Drug Networks

Also known as: PBM Price Transparency and Accountability Act

Legislative Progress

Filed
Review
Senate
House
President

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • Medicaid: States would have to use a pass-through pricing model so PBMs can’t keep “spread” between what the state pays and what pharmacies get.
  • Medicaid: HHS would run monthly surveys to set national drug cost benchmarks and publish results; pharmacies would have to respond or face penalties.
  • Medicare drug plans: Starting in 2028, plans would have to let any pharmacy join the network if it accepts the plan’s standard terms, aiming to protect pharmacy choice.
  • Medicare: HHS would set “reasonable” contract standards, create a complaint process for pharmacies, and allow penalties when plans break the rules.
  • PBMs serving Medicare plans would have to file detailed annual reports on drug costs and payments, pass through certain price breaks, and allow audits; new federal funding supports oversight.
HealthcareMedicare MedicaidEconomy Finance

Milestones

2 milestones2 actions
Dec 4, 2025Senate

Read twice and referred to the Committee on Finance.

Dec 4, 2025

Introduced in Senate

What Happens Next

Projected impacts based on AI analysis

New pharmacy survey and Medicaid pass-through pricing rules begin to take effect

Retail pharmacies must respond to monthly drug cost surveys, and states must start requiring PBMs to pass through full drug payments to pharmacies instead of keeping a hidden "spread." This is the first concrete step toward lowering Medicaid drug costs.

2028-01-01

Medicare Part D any-willing-pharmacy and PBM transparency rules take effect for plan year 2028

Starting January 1, 2028, Medicare drug plans must let any pharmacy join their network if it meets standard terms, PBMs must file detailed annual cost reports, and pharmacies gain a formal complaint process. Seniors and people with disabilities should have more choices about where to fill prescriptions.

short_term

HHS publishes standards for 'reasonable and relevant' pharmacy contract terms

By April 2027, HHS must set standards defining what contract terms PBMs and drug plans can require of pharmacies. This will determine how much real-world protection pharmacies — especially small and rural ones — actually get under the new law.

Related News

3 articles

Source Information

Document Type

Congressional Bill

Official Title

PBM Price Transparency and Accountability Act

Bill NumberS 3345
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.

Sponsor

Cosponsors

(26)
D: 12R: 14

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.